To assess the impact of IGF-I stimulation on the activation of signalling pathways underlying the malignant phenotype, a panel of mesothelioma cell lines and normal mesothelial cells were treated with IGF-I (5 nM) for varying times, followed by immunoblot analysis. This evidence concerns the gene IGF1 and mesothelioma.